Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-18-064123

Director bought 4,713 shares at an average $0.65 ($3,075)

From the SEC's structured data for this filing

Trades in this filing

HILZINGER KURT J · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-12-21 Purchase : show line 1 in the form +3,600 $0.65 $2,340 41,400 D
2018-12-24 Purchase : show line 2 in the form +1,113 $0.66 $735 42,513 D
Open-market purchases · 4,713 sh · avg $0.65 · $3,075
Loading xslF345X03/doc4.xml…